Healthcare Costs and Voter Priorities in US Elections
Explore how healthcare costs impact voter decisions, including Medicaid, Medicare, and recent legislative efforts like the Insulin Reduction Act.
Modernizing Medicare Part D: Proposed PBM Regulations and Their Impact
Explore proposed Medicare Part D PBM regulations aiming to enhance transparency and accountability, reshaping drug pricing strategies and market dynamics.
PhRMA Challenges Medicare's GLOBE Drug-Pricing Initiative
PhRMA's lawsuit against the U.S. government challenges CMS's new Medicare drug-pricing model, impacting costs and pharmaceutical innovation. Stay informed!
Midterm Elections Impact on Drug Pricing and Insurance Practices
Explore the imminent impacts of midterm elections on drug pricing, pharma reforms, and insurance strategies amid changing healthcare policies.
PhRMA Lawsuit Challenges Medicare Drug Price Program
PhRMA is suing the federal government over a new Medicare drug Pricing program. Understand implications for insurance professionals and the pharmaceutical market.
New Drug Payment Model and Its Impact on Medicare | Insurance Insights
Explore the new drug payment model's impact on Medicare and insurance professionals. Understand pricing strategies, exemptions, and regulatory implications.
New Medicaid Pricing Model: Financial Impacts and Future of Drug Costs
Discover how the new Medicaid pricing model aims to reduce drug costs and its potential impact on the insurance industry and healthcare savings.
Dr. Mehmet Oz Predicts Healthcare Cost Surges Despite Drug Price Reductions
Dr. Mehmet Oz warns of rising healthcare costs by 2027 despite recent drug price cuts, highlighting Medicare negotiations and affordability initiatives.
The Role and Impact of Pharmacy Benefit Managers on Healthcare Costs
Explore how pharmacy benefit managers influence drug pricing and healthcare access. Understand their role in mail orders and emerging legislative actions.
Maryland’s Groundbreaking Law on Medicare Prescription Drug Savings
Understand Maryland's new law extending Medicare drug savings, its impact on insurance pricing, and the need for regulatory compliance adjustments.